Mitochondrial protein import stress augments α-synuclein aggregation and neural damage
Open Access
- 10 November 2026
- journal article
- Published by Life Science Alliance, LLC in Life Science Alliance
- Vol. 10 (1) , e202603770
Abstract
Genetic and environmental factors are known to converge on mitochondria to cause Parkinson’s disease. The underlying mechanism is incompletely understood. In addition to bioenergetic defects, nonbioenergetic pathways have been largely unexplored. Validating the nonbioenergetic mitochondrial stressors as independent pathogenic factors is challenging because most mouse models of mitochondrial stress are confounded by bioenergetic defects. Here, we show that expression of Ant1 P.A114P,A123D , previously shown to cause mitochondrial protein import clogging in cultured human cells, does not affect the overall bioenergetic capacity, yet it induces proteostatic stress responses in the cytosol that suggests accumulation of unimported precursor proteins. In a Parkinson’s disease model expressing α-synuclein (A53T), Ant1 P.A114P,A123D increased the size of α-synuclein aggregates, increased aggregation of mitochondrial preproteins, heightened neuroinflammation, and worsened motor coordination defects. Importantly, we found no evidence of bioenergetic defects in either α-synuclein (A53T) or α-synuclein (A53T) + Ant1 P.A114P,A123D mice. These data suggest that Ant1 P.A114P,A123D likely induces mitochondrial protein import stress, and contributes to neural damage through cytosolic proteostatic stress and altered aggregation dynamics of neuropathogenic proteins independent of bioenergetics.Funding Information
- National Institute on Aging (R01AG063499)
- National Institute on Aging (R01AG082803)
- National Institute on Aging (F30AG060702)
- National Institute on Aging (F31AG087692)
- American Heart Association (906215)
This publication has 79 references indexed in Scilit:
- Transcriptome and proteome profiling reveals TREM2-dependent and -independent glial response and metabolic perturbation in an Alzheimer’s mouse modelJournal of Biological Chemistry, 2024
- Common Mechanisms Underlying α-Synuclein-Induced Mitochondrial Dysfunction in Parkinson’s DiseaseJournal of Molecular Biology, 2023
- Microglial CX3CR1 production increases in Alzheimer's disease and is regulated by noradrenalineGlia, 2020
- Insulin-like growth factor 2 (IGF2) protects against Huntington’s disease through the extracellular disposal of protein aggregatesActa Neuropathologica, 2020
- mPOS is a novel mitochondrial trigger of cell death – implications for neurodegenerationFEBS Letters, 2017
- A system to measure the pupil response to steady lights in freely behaving miceJournal of Neuroscience Methods, 2016
- Brain aging, Alzheimer's disease, and mitochondriaBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2011
- The puzzle box as a simple and efficient behavioral test for exploring impairments of general cognition and executive functions in mouse models of schizophreniaExperimental Neurology, 2011
- Isolation of Mitochondria from the CNSCurrent Protocols in Neuroscience, 2010
- Chronic parkinsonism secondary to intravenous injection of meperidine analoguesPsychiatry Research, 1979